Trial NCT01205217

View at ClinicalTrials.gov 
Org. Study IDs: 113957

Last trial update was posted on 2017-06-07

MeSH Interventions

Cyclophosphamide Epirubicin Lapatinib Paclitaxel Trastuzumab

MeSH Conditions

Breast Neoplasms

Other Conditions

Neoplasms, Breast

Stopping Reasons

Data presented at SABCS 2010 showing that dual blockade is superior to monotherapy

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID